pre-IPO PHARMA

pre-IPO PHARMA NEWS


Business

venatorx-pharmaceuticals

09/27/23

Venatorx Pharmaceuticals to Present at IDWeek 2023

omniose

09/27/23

Omniose Awarded NIH Grant of up to $3.0 Million to Develop Vaccines against Group B Streptococcus

imidomics

09/27/23

Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases


geneos-therapeutics

09/27/23

Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 Million

flamingo-therapeutics

09/27/23

Flamingo Therapeutics Announces Participation at Upcoming Investor and Industry Conferences

evommune

09/27/23

Evommune Announces Strategic Collaboration with Maruho to Develop and Commercialize MRGPRX2 antagonist EVO756 in Japan

azurity-pharmaceuticals

09/27/23

Azurity Pharmaceuticals Acquires Slayback Pharma

melt-pharmaceuticals

09/26/23

Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for Its Zydis Fast-Dissolve Technology for Use in MELT-300 for Needle- and Opioid-Free Procedural Sedation

capstan-therapeutics

09/26/23

Capstan Therapeutics to Participate in Upcoming Industry Conferences

alzheon

09/26/23

Alzheon To Present Pivotal Program of Oral ALZ-801/Valiltramiprosate at Singularity Conference, Goldman Sachs Alzheimer’s Disease Day, and BIO Investor Forum

pact

09/25/23

Sustainable Packaging Disruptors Bluebird and Pact Collective Partner to Drive the Beauty Industry Toward Circularity

bexion-pharmaceuticals

09/25/23

Bexion Pharmaceuticals, Inc. to Participate in the 2023 Cantor Global Healthcare Conference

qihan-biotech

09/22/23

Qihan Biotech announces the completion of pre-Series B financing for developing stem cell-derived cell therapy products with high-throughput multiplexable genome editing

micurx

09/22/23

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

transcend-therapeutics

09/21/23

Transcend Therapeutics and Yale awarded U.S. Department of Defense grant to study methylone for PTSD

maze-therapeutics

09/21/23

Maze Therapeutics to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference

lynk-pharmaceuticals

09/21/23

Lynk Pharmaceuticals Completes Series C2 Financing Round, with Total C Round Funding of 322 Million RMB USA - English APAC - English

capsida-biotherapeutics

09/20/23

Capsida Biotherapeutics to Present at Jefferies Cell and Genetic Medicine Summit and the 2023 Cell and Gene Meeting on the Mesa

recode-therapeutics

09/19/23

ReCode Therapeutics Announces Closing of Extension to Series B Financing

rayzebio

09/19/23

RayzeBio, Inc. Announces Closing of Upsized $358 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Science


therapeutic-solutions-international

09/29/23

Therapeutic Solutions International Announces Paradigm Shifting Immunotherapy Product: Tolerogenic Neutrophils

atamyo-therapeutics

09/29/23

Atamyo Therapeutics Announces participation in Conferences and Key Scientific Communications on its LGMD programs

synthekine

09/28/23

First Patient Dosed in Phase 1b Clinical Trial of Synthekine’s α/β Biased IL-2, STK-012, for Treatment of Solid Tumors

profoundbio

09/28/23

ProfoundBio Announces Upcoming Scientific Presentations at SITC 2023

nanoscope-therapeutics

09/28/23

Nanoscope Therapeutics to Present at the 4th Annual Gene Therapy for Ophthalmic Disorders Summit

iaso-bio

09/28/23

IASO Bio Presents Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO (Equecabtagene Autoleucel) at IMS 2023

iaso-bio

09/28/23

Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO (Equecabtagene Autoleucel) at IMS 2023 USA - English APAC - English

fractyl

09/28/23

Fractyl Health to Present Pioneering Data on Revita and Rejuva Programs at the European Association for the Study of Diabetes (EASD) 2023 Scientific Congress

xnk-therapeutics

09/27/23

XNK Therapeutics presented two posters at the NK2023 conference in Oslo USA - English USA - English


tallac-therapeutics

09/27/23

Tallac Therapeutics Announces Two Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

hotspot-therapeutics

09/27/23

HotSpot Therapeutics to Present Preclinical Data from CBL-B Program at 2023 Society for Immunotherapy of Cancer Annual Meeting

cantex

09/27/23

CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AZELIRAGON IN THE TREATMENT OF PATIENTS HOSPITALIZED FOR COVID-19

adcentrx-therapeutics

09/27/23

Adcentrx Therapeutics Announces First Patient Dosed in the Phase 1a/b Study of ADRX-0706, a Novel ADC Targeting Nectin-4 for the Treatment of Advanced Solid Tumors

rarecyte

09/26/23

Recent Nature publications highlight the groundbreaking performance of RareCyte's Orion Spatial Biology platform

elpiscience

09/26/23

Elpiscience Announces First Patient Dosed for Phase 1 Clinical Trial of Anti-LILRB2 Antibody ES009 in Australia

cantex

09/26/23

Cantex and Allegheny Health Network Announce Initiation of a Phase 1/2 Study of Azeliragon in Patients Refractory to First-Line Treatment of Metastatic Pancreatic Cancer

am-pharma

09/26/23

AM-Pharma Announces Updated Clinical Development Strategy

escient-pharmaceuticals

09/25/23

Escient Pharmaceuticals Initiates Clinical Proof-of-Concept Study of EP262, a First-in-Class Oral MRGPRX2 Antagonist, in Chronic Inducible Urticaria

affamed-therapeutics

09/25/23

AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib (Luminate) First-in-Class Candidate for the Treatment of Intermediate Dry AMD USA - English APAC - English

phylex-biosciences

09/22/23

PHYLEX BIOSCIENCES ANNOUNCES NIPAH VIRUS VACCINE INITIATIVE WITH ITS NANOPARTICLE mRNA VACCINE TECHNOLOGY

People

pic-therapeutics

09/28/23

PIC Therapeutics Expands its Team with the Addition of Translational Biology Oncology Leader, Richard Gedrich, PhD as Chief Development Officer


sanotize

09/27/23

SaNOtize’s Board Appoints Steven Basta as New Chief Executive Officer


chroma-medicine

09/27/23

Chroma Medicine Strengthens Leadership with the Appointment of Biotech Business Leader Michael A. Kelly to its Board of Directors


nextrna

09/26/23

NextRNA Therapeutics Strengthens Board of Directors with Appointment of Lori Friedman, PhD


nanoscope-therapeutics

09/21/23

Nanoscope Therapeutics Strengthens Clinical and Regulatory Expertise With Appointment of Samuel Barone, M.D., as Chief Medical Officer


anavo-therapeutics

09/21/23

Anavo Therapeutics Strengthens Management Team



accent-therapeutics

09/21/23

Accent Therapeutics Bolsters Leadership Team with Key Executive Hires


ocuterra

09/19/23

OcuTerra President and CEO Kerrie Brady Named to 2023 PharmaVoice 100 List of Most Inspiring Leaders


auravax-therapeutics

09/19/23

AuraVax Therapeutics recognizes its academic collaborator at the University of Houston for address at Keystone Conference


therapeutic-solutions-international

09/18/23

Therapeutic Solutions International Recruits Internationally Renowned Stem Cell Clinician and San Diego Top Doctor to Scientific Advisory Board


acepodia

09/18/23

Acepodia Announces Nobel Laureate Carolyn Bertozzi, Ph.D., as Chief Scientific Advisor


phanes-therapeutics

09/14/23

Phanes Therapeutics Announces the Appointment of Internationally Renowned Oncologist Prof. Shun Lu to its Clinical Advisory Board


fractyl

09/14/23

Fractyl Health Welcomes Dr. Timothy Kieffer as Chief Scientific Officer


confo-therapeutics

09/12/23

Confo Therapeutics Appoints Stephen Dowd as Chief Business Officer


vividion-therapeutics

09/07/23

Vividion Therapeutics Names Shawn Rose as Chief Development Officer


rapport-therapeutics

09/07/23

Rapport Therapeutics Appoints Chief Operating Officer and Scientific Advisory Board Member


engene

09/07/23

enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer


anokion

09/07/23

Anokion Strengthens its Senior Leadership with Promotions and New Appointment


allay-therapeutics

09/06/23

Allay Therapeutics Appoints Nicole Vitullo to Board of Directors


phanes-therapeutics

09/05/23

Phanes Therapeutics Announces the Establishment of Oncology Clinical Advisory Board


aivita-biomedical

09/05/23

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at Advanced Therapies Europe


akston-biosciences

08/31/23

Akston Biosciences Receives 2023 Most Innovative Award at Animal Health Summit